Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells

Numerous nanocarriers have been developed to deliver drugs for the treatment of hepatocellular carcinoma. However, the lack of specific targeting ability, the low administration efficiency, and insufficient absorption by hepatocellular carcinoma cells, severely limits the therapeutic effect of the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xuanping, Liu, Chuan, Wang, Zichao, Zhao, Yingyuan, Chen, Xuyang, Tao, Haizhen, Chen, Hong, Wang, Xueqin, Duan, Shaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866545/
https://www.ncbi.nlm.nih.gov/pubmed/36678904
http://dx.doi.org/10.3390/pharmaceutics15010276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866545/
https://www.ncbi.nlm.nih.gov/pubmed/36678904
http://dx.doi.org/10.3390/pharmaceutics15010276

Ejemplares similares